Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AGRX

Agile Therapeutics (AGRX) Stock Price, News & Analysis

Agile Therapeutics logo

About Agile Therapeutics Stock (NASDAQ:AGRX)

Advanced Chart

Key Stats

Today's Range
$1.51
$1.52
50-Day Range
$1.43
$1.51
52-Week Range
$0.20
$2.63
Volume
120,938 shs
Average Volume
352,864 shs
Market Capitalization
$10.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AGRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agile Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AGRX Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse... ...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier.
See More Headlines

AGRX Stock Analysis - Frequently Asked Questions

Agile Therapeutics, Inc. (NASDAQ:AGRX) released its quarterly earnings results on Tuesday, November, 2nd. The specialty pharmaceutical company reported ($7.20) earnings per share for the quarter, topping analysts' consensus estimates of ($7.60) by $0.40. The specialty pharmaceutical company earned $1.29 million during the quarter, compared to analyst estimates of $1.49 million.
Read the conference call transcript
.

Agile Therapeutics's stock reverse split on the morning of Wednesday, April 27th 2022.The 1-40 reverse split was announced on Wednesday, April 27th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 27th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Agile Therapeutics investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), CrowdStrike (CRWD) and Arista Networks (ANET).

Company Calendar

Last Earnings
11/02/2021
Today
7/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AGRX
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.47 million
Pretax Margin
-36.24%

Debt

Sales & Book Value

Annual Sales
$19.98 million
Price / Cash Flow
N/A
Book Value
($5.51) per share
Price / Book
-0.27

Miscellaneous

Free Float
6,822,000
Market Cap
$10.35 million
Optionable
Not Optionable
Beta
1.58

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:AGRX) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners